Psychotic Disorders

"Psychotic Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)

Descriptor ID	D011618
MeSH Number(s)	F03.700.675
Concept/Terms	Psychotic Disorders Psychotic Disorders Disorder, Psychotic Disorders, Psychotic Psychotic Disorder Psychosis Psychoses Schizoaffective Disorder Schizoaffective Disorder Disorder, Schizoaffective Disorders, Schizoaffective Schizoaffective Disorders Schizophreniform Disorders Schizophreniform Disorders Disorder, Schizophreniform Disorders, Schizophreniform Schizophreniform Disorder Psychosis, Brief Reactive Psychosis, Brief Reactive Brief Reactive Psychoses Brief Reactive Psychosis Psychoses, Brief Reactive Reactive Psychoses, Brief Reactive Psychosis, Brief

Below are MeSH descriptors whose meaning is more general than "Psychotic Disorders".

Psychiatry and Psychology [F]
Mental Disorders [F03]
Schizophrenia Spectrum and Other Psychotic Disorders [F03.700]
Psychotic Disorders [F03.700.675]

Below are MeSH descriptors whose meaning is related to "Psychotic Disorders".

Below are MeSH descriptors whose meaning is more specific than "Psychotic Disorders".

Psychotic Disorders
Psychoses, Substance-Induced

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Psychotic Disorders" by people in this website by year, and whether "Psychotic Disorders" was a major or minor topic of these publications.

Bar chart showing 126 publications over 28 distinct years, with a maximum of 10 publications in 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	2	0	2
1998	1	0	1
2000	0	1	1
2001	0	1	1
2002	3	0	3
2003	4	1	5
2004	2	0	2
2005	4	0	4
2006	2	2	4
2007	4	1	5
2008	5	2	7
2009	2	0	2
2010	6	0	6
2011	2	1	3
2012	9	1	10
2013	6	2	8
2014	7	0	7
2015	5	1	6
2016	4	0	4
2017	6	0	6
2018	5	0	5
2019	5	0	5
2020	5	0	5
2021	4	2	6
2022	5	0	5
2023	5	0	5
2024	3	3	6
2025	2	0	2

Below are the most recent publications written about "Psychotic Disorders" by people in Profiles.

Carter E, Banerjee S, Alexopoulos GS, Bingham KS, Marino P, Meyers BS, Mulsant BH, Neufeld NH, Rothschild AJ, Voineskos AN, Whyte EM, Flint AJ. Prediction of remission of pharmacologically treated psychotic depression: A machine learning approach. J Affect Disord. 2025 Jul 15; 381:291-297.

View in: PubMed
DeLuca JS, Berrett-Abebe J, Pagnotta M, Binger B, McClure MM. Evaluating an Early-Stage Psychosis Training Program for Interdisciplinary Mental Health Students and Trainees: A Mixed-Methods Pilot Study. Early Interv Psychiatry. 2025 Feb; 19(2):e70008.

View in: PubMed
Bareis N, Edlund M, Ringeisen H, Guyer H, Dixon LB, Olfson M, Smith TE, Chwastiak L, Monroe-DeVita M, Swartz M, Swanson J, Sinclair Hancq E, Geiger P, Kreski NT, Stroup TS. Characterizing Schizophrenia Spectrum Disorders: Results of the U.S. Mental and Substance Use Disorders Prevalence Study. Psychiatr Serv. 2025 Jan 01; 76(1):2-12.

View in: PubMed
Ihaddadene RA, Alexopoulos GS, Marino P, Meyers BS, Mulsant BH, Neufeld NH, Rothschild AJ, Voineskos AN, Whyte EM, Flint AJ, Bingham KS. Predictors of attrition during acute pharmacotherapy of psychotic depression in a clinical trial. Psychiatry Res. 2024 Dec; 342:116192.

View in: PubMed
Cintr?n Pastrana MA, Irizarry Flores JC, Rothschild AJ. Challenges in the Treatment of Psychotic Bipolar Depression. J Clin Psychopharmacol. 2024 Jul-Aug 01; 44(4):407-412.

View in: PubMed
Kim HK, Voineskos AN, Neufeld NH, Alexopoulos GS, Bingham KS, Flint AJ, Marino P, Rothschild AJ, Whyte EM, Mulsant BH. Effect of olanzapine exposure on relapse and brain structure in patients with major depressive disorder with psychotic features. Mol Psychiatry. 2024 Aug; 29(8):2459-2466.

View in: PubMed
Lee J, Xue X, Au E, McIntyre WB, Asgariroozbehani R, Panganiban K, Tseng GC, Papoulias M, Smith E, Monteiro J, Shah D, Maksyutynska K, Cavalier S, Radoncic E, Prasad F, Agarwal SM, Mccullumsmith R, Freyberg Z, Logan RW, Hahn MK. Glucose dysregulation in antipsychotic-naive first-episode psychosis: in silico exploration of gene expression signatures. Transl Psychiatry. 2024 Jan 10; 14(1):19.

View in: PubMed
Rothschild AJ. Maintenance treatment of psychotic depression: Is antipsychotic medication needed? Acta Psychiatr Scand. 2024 01; 149(1):3-5.

View in: PubMed
Lee J, Xue X, Au E, McIntyre WB, Asgariroozbehani R, Tseng GC, Papoulias M, Panganiban K, Agarwal SM, Mccullumsmith R, Freyberg Z, Logan RW, Hahn MK. Central insulin dysregulation in antipsychotic-na?ve first-episode psychosis: In silico exploration of gene expression signatures. Psychiatry Res. 2024 Jan; 331:115636.

View in: PubMed
Banerjee S, Wu Y, Bingham KS, Marino P, Meyers BS, Mulsant BH, Neufeld NH, Oliver LD, Power JD, Rothschild AJ, Sirey JA, Voineskos AN, Whyte EM, Alexopoulos GS, Flint AJ. Trajectories of remitted psychotic depression: identification of predictors of worsening by machine learning. Psychol Med. 2024 Apr; 54(6):1142-1151.

View in: PubMed

People

Explore

Similar Concepts

Top Journals